Dhanesh Amarnani

1 Patent

• US117393262023

  RUNX1 Inhibition for Treatment of Proliferative Vitreoretinopathy and Conditions Associated with Epithelial to Mesenchymal Transition

  The Schepens Eye Research Institute, Inc.

  0 cites